Norditropin 48 IU Novo Nordisk | TPT0165

Norditropin 48 IU Novo Nordisk | TPT0165 buy
Norditropin 48 IU Novo Nordisk | TPT0165
Brand:Novo Nordisk
Product Code:TPT0165
Availability:In Stock
  • 95.00€
Available Options

Norditropin 48 IU Novo Nordisk product description

The popularity of Norditropin is due to the fact that its action is excellent for building muscle mass, which has a relief appearance that is highly valued among athletes.

Norditropin 48 IU Novo Nordisk is a preparation of somatotropic hormone. It stimulates skeletal and somatic growth and has a pronounced effect on metabolic processes. Norditropin 48 IU Novo Nordisk, by filling in the deficiency of endogenous growth hormone, helps normalise body structure by increasing muscle mass and reducing body fat.

Application:

Most of the effects of Norditropin are realized through insulin-like growth factor I (IRF I), which is produced in all cells of the body (mainly liver cells). More than 90% of IRF-I is associated with proteins (IRFSB), of which IRFSB-3 is the most important.

Norditropin enhances bone restructuring, which is manifested by the increased activity of biochemical bone markers in plasma. In adults, due to more pronounced bone resorption, bone mass decreases during the first months of treatment, but bone mass increases as treatment continues.

Side effects:

Possible: increased intracranial pressure (headache, nausea, vomiting, visual impairment), reduced thyroid function, hyperglycemia, leukemia, femoral head epiphysis, fluid retention with peripheral edema, arthralgia, myalgia, tunnel syndrome. Symptoms are usually transitory, dose-dependent and may require dose reduction.

Allergic reactions: skin rash, itching.

Rare: the formation of antibodies to the drug with reduced effectiveness.

Local reactions: Hyperemia, swelling, pain, itching, lipoatrophy at the injection site.

Contraindications for use:

  • malignant neoplasms;
  • active brain tumours;
  • Urgent conditions (including conditions after heart, abdominal and acute respiratory failure);
  • pregnancy;
  • period of breastfeeding (breastfeeding must be abandoned for the duration of treatment);
  • hypersensitivity to the components of the drug.

The drug should be administered with caution in case of diabetes mellitus, intracranial hypertension, hypothyroidism.

Country Denmark
Substance Somatropin
Active ingredient, mg 15
Packaging Cartridge
Active ingredient, IU 48
Manufacturer Novo Nordisk
Write a review
Note: HTML is not translated!
    Bad           Good